Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trustmanic who wrote (92)	3/4/1997 2:13:00 PM
From: Ron Kertesz	of 1185

Hello Gentleman, The news release will be available on our web-site today (I've been a bit busy this morning and haven't had a chance to get it on yet). To answer your question George: Drs. MacLeod and Quastel will receive milestone payments if the compounds progress through later stages of clinical trials and then reach the market. The $3million we announced recently will fund drug research and clinical development and will not go to payments for the Nociblockers. Money for the milestone payments will likely come from any milestone payments Nortran receives as these compounds are licensed out. Cheers, Ron

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next